cancer-therapy

Documents about cancer-therapy

• Radiation-induced esophagitis and lung injury during esophageal squamous cell cancer therapy is correlated to tumor gene expression phenotype.#152200NCBI PubMed Central
• Methylene Blue (mb) Loaded Zif-8 Synthesis, Characterization and Investigation of Photodynamic Therapy Activity on Breast Cancer#195207İzmir Yüksek Teknoloji Enstitüsü
• Data for: "Assessing the association between endocrine therapy use in female breast cancer survivors and subsequent risk of cardiovascular disease"#206157LSHTM Data Compass
• Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer#217018ClinicalTrials.gov
• Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma#230418ClinicalTrials.gov
• Recanalization therapy in stroke patients with malignancies: in-hospital outcomes by cancer subtype in a nationwide administrative data analysis.#244403NCBI PubMed Central
• Monoclonal antibody immune therapy response instrument for stratification and cost-effective personalized approaches in 3PM-guided pan cancer management.#247626NCBI PubMed Central
• Genomic Profiling: Can We Rely on Retrospective Analysis to Drive Changes in Clinical Practice?#250621IRIS
• A computational framework for optimizing radioiodine therapy protocols in metastatic thyroid cancer#273923HAL (France)
• HFHS-1801-A Pilot Study of Immunotherapy As Consolidation Therapy for Patients with Recurrent Head and Neck Cancer#279527ClinicalTrials.gov
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma That Has Not Responded to Previous Treatment#283098ClinicalTrials.gov
• Supplementary Material for: Relationship of Renal Replacement Therapy to Cancer Site:A Hospital-Based Analysis in Osaka, Japan#353661Figshare
• Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer.#406488NCBI PubMed Central
• KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors#414486ClinicalTrials.gov
• Effect of mat Pilates on postural control in breast cancer survivors receiving endocrine therapy: a randomized controlled clinical trial#439760Repositório Institucional Unesp
• Predictive value of 18F-FDG PET/CT delta radiomics model for prognosis after neoadjuvant therapy for locally advanced pancreatic cancer.#455298NCBI PubMed Central
• Longitudinal [(18)F]FDG PET/MR Assessment of Arterial Inflammation in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy.#465317NCBI PubMed Central
• Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract#633734ClinicalTrials.gov
• Combining Epigenetic And Immune Therapy to Beat Cancer.#668813ClinicalTrials.gov
• Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial#28299ClinicalTrials.gov
• Feasibility of high-throughput sequencing in clinical routine cancer care: lessons from the cancer pilot project of the France Genomic Medicine 2025 plan#147581HAL (France)
• Short-course Radiation (SCRT) Followed by 6 Cycles of Cadonilimab Plus MFOLFOX6 As Neoadjuvant Therapy for Patients with Locally Advanced Rectal Cancer (LARC): a Multicenter, Two-arm Parallel, Open-label, Randomised Phase III Trial (NeoCaCRT-III)#158200ClinicalTrials.gov
• How to best exploit immunotherapeutics in advanced gastric cancer: between biomarkers and novel cell-based approaches#250634IRIS
• Zanidatamab Combined With Chemotherapy as Neoadjuvant/Conversion Therapy for HER2-Positive (IHC 3+ or IHC 2+) Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a Phase II Open-Label Study#394773ClinicalTrials.gov
• Perspectives and Requirements of Patients with Prostate Cancer on Mobile Health Interventions During Androgen Deprivation Therapy: A Descriptive Qualitative Study.#512NCBI PubMed Central
• Translation approaches to support systemic anti-cancer therapy consent for individuals with limited English proficiency.#9550PubMed
• Polo-like Kinase 1 As Target For Cancer Therapy#19624OpenCitations
• Causal modeling reveals cell–cell communication dynamics in the tumor microenvironment during anti-PD-1 therapy in breast cancer patients.#67452NCBI PubMed Central
• Surface-guided radiation therapy combined with real-time position management-guided deep inspiratory breath-hold radiotherapy for left breast cancer.#125562NCBI PubMed Central
• Real-world EHR-derived progression-free survival across successive lines of therapy informs metastatic breast cancer risk stratification#135527Unpaywall
• ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy#162481ClinicalTrials.gov
• Endocrine therapy in advanced high-grade ovarian cancer: real-life data from a multicenter study and a review of the literature#168473HAL (France)
• The RESILIENT Study: A Retrospective, Descriptive, Correlational Investigation of Correlates of Oral Endocrine Therapy Adherence in Older Women With Breast Cancer.#170480NCBI PubMed Central
• Feasibility study of the Four-Session Cognitive-Behavioral Therapy-based Psychological Intervention Program for women with HER2-positive metastatic breast cancer.#193326NCBI PubMed Central
• Circular RNAs in tumorigenesis: an insight into recent research in biogenesis and targeted tumor therapy#215385Europe PMC
• Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer#230413ClinicalTrials.gov
• A pilot study of a behavior-change intervention for preventive therapy among women at high risk for invasive breast cancer.#242448NCBI PubMed Central
• Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy#272348ClinicalTrials.gov
• Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL#287527ClinicalTrials.gov
• Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer#311126ClinicalTrials.gov
• Synthetic biology of oncolytic bacteria: Comparative microbial chassis and precise killing strategies#311598Europe PMC
• Intrinsically Disordered Polypeptides-Based Stealth Materials Enable Enhanced Photothermal Cancer Therapy Using an In Situ Fiber-Based Penetrating Laser System.#392727NCBI PubMed Central
• Integrative Multiomics Analysis Reveals a Cancer Stem Cell-Driven Prognostic Signature and Nominates Belinostat for Targeted Therapy in Hepatocellular Carcinoma.#427731NCBI PubMed Central
• Total Neoadjuvant Therapy With Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Ultra Low Rectal Adenocarcinoma#432877ClinicalTrials.gov
• A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC#435737ClinicalTrials.gov
• Use of Information and Communication Technologies in Patients With Cancer Receiving Antineoplastic or Supportive Therapy: Comparative Cross-Sectional Survey.#439245NCBI PubMed Central
• Bispecific antibodies for cancer therapy: evolution of structural formats and co-targeting strategies from wet-lab to AI-driven in silico modeling.#442911NCBI PubMed Central
• Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC#444878ClinicalTrials.gov
• MRI-Based Structured Assessment of Treatment Response in Rectal Cancer After Total Neoadjuvant Therapy: Correlation With Surgical and Pathological Outcomes.#480937NCBI PubMed Central
• Hepatocellular Carcinoma#486867Directory of Open Access Books